From Health Policy Expert to Patient: The Perils of Navigating Insurance
PhRMA Foundation President Dr. Amy M. Miller discusses the barriers rare disease patients face in accessing these medicines.
BlogPhRMA Foundation President Dr. Amy M. Miller discusses the barriers rare disease patients face in accessing these medicines.
BlogPriscila Halicki, a postdoc at the University of Central Florida, aims to improve the process for finding new tuberculosis drugs from natural products.
BlogThis educational module presents a comprehensive overview of adverse drug reactions (ADRs), including factors the increase the likelihood of an ADR occurring and why it is important to report ADRs.
PageHead of Operations
PhRMA Foundation
SVP and Head of Discovery
Preclinical and Translational Medicine
Merck Research Laboratories